CRIS Current Research Information System

GRAMENZI, ANNAGIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.514
EU - Europa 3.651
AS - Asia 1.899
AF - Africa 256
SA - Sud America 19
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.345
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.502
GB - Regno Unito 986
CN - Cina 637
SE - Svezia 633
IT - Italia 548
SG - Singapore 488
VN - Vietnam 446
DE - Germania 441
IN - India 190
UA - Ucraina 178
IE - Irlanda 167
RU - Federazione Russa 143
FR - Francia 134
CH - Svizzera 127
TG - Togo 114
ZA - Sudafrica 75
EE - Estonia 74
JO - Giordania 71
BG - Bulgaria 53
FI - Finlandia 41
BE - Belgio 34
CI - Costa d'Avorio 33
IR - Iran 23
GR - Grecia 21
NL - Olanda 20
HR - Croazia 18
NG - Nigeria 18
SC - Seychelles 16
CA - Canada 11
EC - Ecuador 8
JP - Giappone 8
CL - Cile 7
ES - Italia 7
LB - Libano 7
ID - Indonesia 5
KR - Corea 5
AU - Australia 4
DK - Danimarca 4
HK - Hong Kong 4
PL - Polonia 4
PT - Portogallo 4
RO - Romania 4
UZ - Uzbekistan 4
CZ - Repubblica Ceca 3
MK - Macedonia 3
MY - Malesia 3
AT - Austria 2
BR - Brasile 2
KZ - Kazakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BO - Bolivia 1
EU - Europa 1
GL - Groenlandia 1
LU - Lussemburgo 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
TH - Thailandia 1
TR - Turchia 1
Totale 11.345
Salva come PNG Salva come JPEG
Città #
Southend 882
Fairfield 756
Chandler 545
Singapore 430
Ashburn 424
Woodbridge 335
Houston 327
Dong Ket 326
Seattle 279
Wilmington 268
Cambridge 241
Ann Arbor 231
Santa Clara 222
Princeton 215
Dublin 167
Bologna 142
Boardman 139
Bern 117
Lomé 114
Jacksonville 109
Westminster 88
Padova 77
Nanjing 74
Amman 71
Berlin 60
Redmond 57
Sofia 50
Beijing 49
Shenyang 49
Jinan 48
Saint Petersburg 45
San Diego 42
New York 41
Helsinki 39
Florence 37
Turin 37
Brussels 34
Milan 34
Abidjan 33
Changsha 31
Bremen 28
Medford 26
Nanchang 24
Dearborn 23
Hebei 22
Tianjin 21
Des Moines 19
Jiaxing 19
Mülheim 19
Abeokuta 18
Norwalk 18
Falls Church 16
Hangzhou 16
Mahé 16
Guangzhou 15
Paris 14
Shanghai 14
Zhengzhou 14
Redwood City 13
Los Angeles 12
Olalla 12
Wuhan 12
Falkenstein 11
London 11
Ningbo 11
Phoenix 11
Washington 11
Rome 10
Munich 9
Zanjan 9
Hyderabad 8
Las Vegas 8
Mountain View 8
Fort Worth 7
Frankfurt Am Main 7
Fremont 7
Lübeck 7
Tokyo 7
Ardabil 6
Bühl 6
Costa Mesa 6
Genoa 6
Guayaquil 6
Haikou 6
Kuban 6
Lanzhou 6
Leawood 6
Saint Louis 6
Taiyuan 6
Chicago 5
Frankfurt am Main 5
Fuzhou 5
Jakarta 5
Kiev 5
Kunming 5
Moscow 5
Napoli 5
Reggio Nell'emilia 5
San Francisco 5
Verona 5
Totale 7.919
Salva come PNG Salva come JPEG
Nome #
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 216
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 187
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 185
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 171
Computed Tomography-Colonography With Intravenous Contrast Medium and Urographic Phase for the Evaluation of Pelvic Deep Infiltrating Endometriosis of Intestinal and Urinary Tract 167
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation. 166
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 166
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. 165
null 164
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 161
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 159
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 year multicentre experience. 152
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 150
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 148
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 148
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 146
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 144
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. 143
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. 141
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 141
Monofocal hepatocellular carcinoma: How much does size matter? 140
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 138
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 138
Alcoholic liver disease: pathophisiological aspects and risk factors. A review. 136
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 136
Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis 135
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study 135
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 132
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 132
Vitamins in the treatment of chronic viral hepatitis. 130
Metabolic disorders across hepatocellular carcinoma in Italy 128
The changing scenario of hepatocellular carcinoma in Italy: an update 128
Liver transplantation for patients with alcoholic liver disease: an open question 127
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 127
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 126
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 124
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance. 122
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 122
Authors’ reply: Comment to “Liver transplantation for patients with alcoholic liver disease: An open question” 122
Hepatitis B virus and immune response. 120
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. 119
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 118
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 118
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 117
null 117
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 116
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma 116
Stem cell mobilization and collection in patients with liver cirrhosis. 112
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence 112
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 112
Years of life that could be saved from prevention of hepatocellular carcinoma. 111
Two years Mycophenolate Mofetil plus low dose calcineurin inhibitor for renal dysfunction after liver transplantation. 111
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 111
Metronomic capecitabine in advanced hepatocellular carcinoma patients:a phase II study. 110
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C. 110
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 110
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. 109
Pattern of macrovascular invasion in hepatocellular carcinoma 108
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study. 107
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. 106
Redefinition of diagnostic role of inferior vena cava ultrasonography in the identification of acute heart failure. 105
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study 104
Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation 104
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 104
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS). 103
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. 102
Probiotics History. 96
Reply to: "Sorafenib or (90) Y loaded resin microsphere radioembolization for locally-advanced hepatocellular carcinoma, what should we trust?" 96
Hepatic artery stenosis in liver transplanted patients treated with pegylated Interferon alpha-2b and Ribavirin 95
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 95
Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? 94
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE. 94
PEGYLATED INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION 92
Development and validation of a scoring system that includes corrected QT interval for risk analysis of patients with cirrhosis and gastrointestinal bleeding 91
Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score Analysis 89
TRANS-ARTERIAL RADIOEMBOLIZATION FOR INTERMEDIATE-ADVANCED HEPATOCELLULAR CARCINOMA: A BUDGET IMPACT ANALYSIS 86
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis 85
Vitamin E as treatment for chronic viral hepatitis: is it time to perform large clinical trials? 84
null 83
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 81
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver. 78
The evolutionary scenario of hepatocellular carcinoma in Italy: an update. 74
null 73
null 72
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study. 71
La radioembolizzazione nel trattamento del colangiocarcinoma intraepatico inoperabile: efficacia, sopravvivenza e sicurezza 71
null 70
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 70
Post-transplantation lymphoproliferative disorders in liver transplanted patients: a report of four cases 69
Capitolo 14 "Epatiti Virali Croniche", Volume IX "Malattie del Fegato, delle Vie Biliari e del Pancreas", Trattato di Medicina Interna, fondato da Paolo Larizza 67
Fegato e infezioni sistemiche. 65
Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? 61
The changing scenario of hepatocellular carcinoma in Italy: an update 59
SPONTANEOUS MOBILIZATIONOF BONE MARROW-DERIVED HEMATOPOIETIC AND ENDOTHELAIL PROGENITOR CELLS AFTER ORTHOTOPIC LIVER TRANSPALNTATION (OLT). 58
Sorafenib versus Y90 radioembolization in cirrhotic patients with hepatocellular carcinoma (HCC): cohort and nested control-case study with propensity analysis 55
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 51
Radioembolizzazione con 90Y versus sorafenib nei pazienti cirrotici con carcinoma epatocellulare (HCC): studio monocentrico con analisi di propensity 48
A modified Child-Turcotte-Pugh (CTP) for selection of patients affected by cirrhosis candidates for liver transplantation (LT) with low model for end-stage liver disease score (MELD) 48
Role of CT colonography (CTC) in a regional colorectal cancer (CRC) screening programme: preliminary results. 47
A modified Child-Turcotte-Pugh (CTP) for selection of candidates to liver transplantation (LT) with low model for end-stage liver disease score (MELD). 45
Totale 11.203
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.747 0 0 0 0 0 278 344 343 369 177 86 150
2020/20211.548 276 108 31 72 14 64 32 75 166 77 82 551
2021/20222.179 159 86 121 203 173 124 57 136 63 168 567 322
2022/20232.413 236 369 114 321 122 192 87 121 403 80 191 177
2023/2024634 51 97 41 56 59 153 17 45 29 31 23 32
2024/20251.330 91 364 194 191 353 137 0 0 0 0 0 0
Totale 11.574